MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.

While the pharmaceutical industry is currently exempt from US tariffs, there is an increased risk to the stability of the ...

Funding troubles and innovation responsibilities are falling more heavily on emerging biotechs under strain from US ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for BridgeBio Pharma’s ...

CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.

Prilenia has signed a partnership and licence agreement with Ferrer for jointly developing and commercialising pridopidine in ...

Biotech Biohaven has signed a non-dilutive funding deal with Oberland Capital as it awaits an FDA ruling on its ...